Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07033975

A Specialized Diet for Multiple Sclerosis

This study examines the impact of a Mediterranean diet on individuals with multiple sclerosis (MS). MS is a multifactorial disease in which environmental factors, such as nutrition, can influence disease progression. Therefore, this study aims to investigate whether a healthier dietary pattern, specifically a flavonoid-rich Mediterranean diet, can affect disease parameters.

Recruiting

Interested in participating?

Request Info

Key information

Age range

30 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hasselt University

Diepenbeek, Limburg, 3590, Belgium

Location status: Recruiting

Location contact

Jerome JA Hendriks, Professor

CONTACT

[email protected]

+3211269207

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Expanded Disability Status Scale (EDSS): 0-6

Exclusion criteria

  • Diagnosed digestive pathology

Treatment and study plan

Flavonoid-enriched Mediterranean Diet

Other

A set of dietary guidelines describing an adjusted Mediterranean diet focusing on the intake of flavonoid-rich products.

Primary outcomes

  1. Microbiota changes

    Time frame: Three timepoints, before start of the strict diet (day 14), after the strict diet (day 31), and after the follow-up period of three months (day 122).

    Microbiota sequencing on fecal samples to identify the different bacterial strains that are present.

Study contacts

Contact information is provided by the study sponsor or research team.

Jerome JA Hendriks, Professor

CONTACT

[email protected]

+3211269207

Sponsors and collaborators

Lead sponsor

Jerome J. A. Hendriks

Other

Collaborators

  • Revalidatie & MS Centrum Overpelt

Registry information

Official study title

A Flavonoid-enriched Mediterranean Diet for Multiple Sclerosis

Acronym: FLAMEMS

Important dates

Study start
2023
Primary completion
2028
Study completion
2028
First posted
Jun 24, 2025
Registry last updated
Jun 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.